Fe3 Medical develops a drug delivery technology for non-toxic iron transportation across the skin for patients with iron-deficiency anemia.
Fe3 Medical Inc. engages in commercialization of a drug delivery technology that enables the safe, non-toxic transport of approximately 10 milligrams of iron across the skin for those who suffer with iron-deficiency anemia.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 8, 2016 | Series B | $3.50M | 1 | — | — | Detail |
| Mar 2, 2016 | Series B | $11M | 1 |
|
— | Detail |
| Sep 28, 2010 | Series Unknown | $2.80M | 1 |
Texas Wide Open for Business
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Texas Wide Open for Business
|
Yes | Series Unknown |
|
|
— | Series B |